Use this URL to cite or link to this record in EThOS:
Title: Cancer prevalence in the United Kingdom : current estimates, future projections and health service utilisation among cancer survivors
Author: Maddams, Jacob
Awarding Body: King's College London (University of London)
Current Institution: King's College London (University of London)
Date of Award: 2012
Availability of Full Text:
Access from EThOS:
Access from Institution:
Cancer prevalence is an important epidemiological measure of the disease burden. It is defined as the number of people in a given population who are alive at a specified point in time (the index date) and who have previously been diagnosed with cancer. It may be expressed as either a count or as a proportion of the population. Members of the prevalent population are known as 'cancer survivors' and the time spent as such is known as 'cancer survivorship'. Complete prevalence includes all survivors regardless of when they were diagnosed, whereas N-year limited duration prevalence includes only those who have received at least one cancer diagnosis in the N years prior to the index date. In the United Kingdom (UK), addressing the needs of cancer survivors is a high priority for the Department of Health, as well as for voluntary sector organisations, and the need for further research into cancer survivorship has been highlighted. Despite this, in recent years little study has focused on cancer prevalence in the UK. The aims in preparing this thesis were to provide up-to-date estimates of cancer prevalence in the UK, to describe levels of acute health service utilisation among cancer survivors in different temporal phases of survivorship and to provide projections of future cancer prevalence. National cancer registry data for the UK were analysed, together with National Health Service hospital activity data for England. It was found that there are currently around two million cancer survivors in the UK, a figure far higher than previously thought. Levels of acute in-patient health service utilisation were, however, generally low among cancer survivors who had survived at least five years and who were not in the final year of their life. A discrete time model for projecting cancer prevalence was derived and used to project cancer prevalence in the UK from 2009 to 2040 under various different scenarios of future cancer incidence and survival. It was shown that in the coming decades cancer prevalence is likely to increase substantially. This thesis contains a detailed description of cancer prevalence and aspects of cancer survivorship in the UK which highlights the need for adequate planning to meet the many and varied needs of those diagnosed with cancer.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available